Erratum
for
Wu et al., J Clin Oncol 25 (21) 3024-3030.
Journal of Clinical Oncology, Vol 25, No 30 (October 20), 2007: pp. 4862
© 2007 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2007.14.1069
ERRATUM
The July 20, 2007, article by Wu et al entitled, "Tamoxifen, Soy, and Lifestyle Factors in Asian American Women With Breast Cancer" (J Clin Oncol 25:3024-3030, 2007) contained errors.
In Table 2, under the Variable column, the unit for blood isoflavone, blood genistein, and blood daidzein levels was given as nmol/L, whereas it should have been µmol/L. Also, the second and third cutpoints for blood isoflavone were given as > 0-  0.05 and > 0.5- 0.24, whereas they should have been > 0-0.05 and > 0.05 0.24 respectively. For blood genistein, the second and third cutpoints were given as > 0- 0.04 and > 0.4- 0.14, whereas they should have been > 0-0.04 and > 0.04 0.14 respectively. For blood daidzein, an erroneous less than or equal to symbol () appeared in the second cutpoint, which should have read > 0-0.028. The corrected table is reprinted below in its entirety.
View this table:
[in this window]
[in a new window]
|
Table 2. Adjusted* Geometric Mean Levels of Tamoxifen and Metabolites by Blood Isoflavone Levels and Self-Reported Intake of Soy
|
|
In the References section, the citation for reference no. 6 was incorrect, and should have read:
Constantinou AI, White BE, Tonetti D, et al: The soy isoflavone daidzein improves the capacity of tamoxifen to prevent mammary tumors. European J Cancer 41: 647-654, 2005.
|
